search
Back to results

Hybrid Blood Pressure Monitor Validation (NISSEI)

Primary Purpose

Essential Hypertension

Status
Completed
Phase
Phase 4
Locations
Greece
Study Type
Interventional
Intervention
Blood Pressure Measurement
Sponsored by
University of Athens
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Essential Hypertension focused on measuring Blood pressure measuring devices, Essential Hypertension, Automated blood pressure measurement

Eligibility Criteria

25 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Above 25 years of age
  • Sinus rhythm
  • Informed consent

Exclusion Criteria:

  • Sustained arrhythmia
  • Pregnancy
  • Poor quality Korotkoff sounds
  • Unavailable cuff size
  • Completed blood pressure range (according to protocol)

Sites / Locations

  • Hypertension Center, Third Department of Medicine, University of Athens, Greece

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

All patients

Arm Description

All eligible patients in the study consist a single group and the same intervention is assigned to all of them.

Outcomes

Primary Outcome Measures

Systolic Blood Pressure Measured by Tested Device.
Mean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Systolic Blood Pressure Measured With Mercury Sphygmomanometer.
Mean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Diastolic Blood Pressure Measured by Tested Device.
Mean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.
Mean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.

Secondary Outcome Measures

Full Information

First Posted
May 6, 2010
Last Updated
April 14, 2012
Sponsor
University of Athens
search

1. Study Identification

Unique Protocol Identification Number
NCT01120990
Brief Title
Hybrid Blood Pressure Monitor Validation
Acronym
NISSEI
Official Title
Validation of a Hybrid Blood Pressure Monitor to Replace the Mercury Standard for Validation Studies According to Modified Criteria of the European Society of Hypertension International Protocol 2010
Study Type
Interventional

2. Study Status

Record Verification Date
April 2012
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
July 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Athens

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Assessment of the accuracy of a Blood Pressure Measuring Device with a digital display-column, NISSEI DM 3000, according to an adaptation of the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults".
Detailed Description
According to the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults", 33 patients have their blood pressure measured by two observers using parallel connected mercury sphygmomanometers, blinded from each other's result, and then by the supervisor using the tested device, NISSEI DM 3000. The measurements using the mercury sphygmomanometers are repeated 5 times and in between them, 4 measurements using the tested device take place. If the results of the comparison of these measurements according to the analysis required by the protocol, meet the required criteria, the device is regarded as "Pass", otherwise as "Fail". In this study, instead of consecutive, simultaneous measurements of the two mercury sphygmomanometers and tha tested device will be taking place. This will be so to exclude any inaccuracy due to blood pressure variability and because the tested device has a controllable deflation rate and allows simultaneous measurements with the mercury sphygmomanometers. In addition, the investigators will be performing 6 set of measurements instead of 4.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Essential Hypertension
Keywords
Blood pressure measuring devices, Essential Hypertension, Automated blood pressure measurement

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
51 (Actual)

8. Arms, Groups, and Interventions

Arm Title
All patients
Arm Type
Other
Arm Description
All eligible patients in the study consist a single group and the same intervention is assigned to all of them.
Intervention Type
Other
Intervention Name(s)
Blood Pressure Measurement
Intervention Description
All patients have their blood pressure measured simultaneously by two observers using parallel connected mercury sphygmomanometers and by a supervisor using the tested device, NISSEI DM 3000. Six sets of measurements are performed.
Primary Outcome Measure Information:
Title
Systolic Blood Pressure Measured by Tested Device.
Description
Mean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Time Frame
3 months
Title
Systolic Blood Pressure Measured With Mercury Sphygmomanometer.
Description
Mean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Time Frame
3 months
Title
Diastolic Blood Pressure Measured by Tested Device.
Description
Mean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Time Frame
3 months
Title
Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.
Description
Mean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Above 25 years of age Sinus rhythm Informed consent Exclusion Criteria: Sustained arrhythmia Pregnancy Poor quality Korotkoff sounds Unavailable cuff size Completed blood pressure range (according to protocol)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
George S Stergiou, MD
Organizational Affiliation
Hypertension Center, Third Depertment of Medicine, University of Athens, Greece
Official's Role
Study Chair
Facility Information:
Facility Name
Hypertension Center, Third Department of Medicine, University of Athens, Greece
City
Athens
Country
Greece

12. IPD Sharing Statement

Learn more about this trial

Hybrid Blood Pressure Monitor Validation

We'll reach out to this number within 24 hrs